Moreover, drugs such as fenofibrate and aspirin, which target TFEB and PPAR-α, respectively, have also shown potential in stroke prevention and AD treatment by activating PPAR-α to upregulate TFEB and increase lysosomal biogenesis170. The gene discussed is TFEB; the disease is stroke disorder.